Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance.
about
Effects of hepatic drug-metabolizing enzyme induction on clinical pathology parameters in animals and man.The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions.Studies on induction of lamotrigine metabolism in transgenic UGT1 mice.Importance of UDP-glucuronosyltransferase 1A1 expression in skin and its induction by UVB in neonatal hyperbilirubinemiaThe role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism.Liver enzyme induction and inhibition: implications for anaesthesia.The pharmacogenomics of HIV therapy.Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: the experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugation.Pharmacogenomics of drugs affecting the cardiovascular system.The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy.Drug bioactivation, covalent binding to target proteins and toxicity relevance.Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene.Variable response to opioid treatment: any genetic predictors within sight?Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk.Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: clinical and experimental studies.Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus.Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects.Genetic Variations in Bilirubin Metabolism Genes and Their Association with Unconjugated Hyperbilirubinemia in Adults.Pharmacogenetics of Adverse Drug Reactions
P2860
Q33618803-D1023BE3-ADF2-4A5C-9626-7C3C90FE6211Q33724160-5DCEDE37-D24D-4466-BEF2-8238DBE41CD7Q33937214-4AFBA465-9DA4-433A-9282-D55E64243A63Q34364347-2C58D362-C3A1-4F65-9F45-E3404199D1DDQ34479006-527DCBA4-D7BC-457D-B2F6-80C08DDFBE70Q34487131-0B400697-7854-4952-B561-CB23C9CDF397Q34574033-0DE0B2C7-BBAC-4A63-B3B9-9939B5F005CBQ35027930-AF6CB8B5-D391-43CD-AE47-950E752A4779Q35127795-D00F7D85-9EC2-4168-BA7C-844C36C8B342Q35129048-BD9CBA3D-FEE6-4E6B-A5F2-34EFC33F6104Q35666588-E2AF8EEE-403A-4C9B-9E54-49F98D1365C1Q36061821-B4C0B558-C2CD-4F10-A24C-B3314E2B1C2FQ36453603-9229A119-63EB-4029-81C7-DB8B9D216148Q37187101-95EFA052-C355-4F35-8CA0-6620DEF52C28Q37715233-52C8C9C8-F743-4700-8642-A6A901F51CABQ38717288-C1E06DE2-A39F-4179-8EB3-1FCF576C18F2Q41893144-E637451C-BC51-479E-8EB9-2B86CC37CAB8Q44601143-C7FD7FC6-4BD6-41B4-A08D-D0408EB6A484Q46140095-236CE5D4-C418-4599-ABF1-1B778FA61670Q46422717-13C0D8D3-4F0D-4FCD-854A-A756874C0C9AQ51272853-D66FFBFD-21BF-4B6E-BBA8-5651A5A835E8Q57302675-D46FD42B-8B7A-416F-96CC-3AB6430679B4
P2860
Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Polymorphisms in UDP glucurono ...... uences and clinical relevance.
@ast
Polymorphisms in UDP glucurono ...... uences and clinical relevance.
@en
Polymorphisms in UDP glucurono ...... uences and clinical relevance.
@nl
type
label
Polymorphisms in UDP glucurono ...... uences and clinical relevance.
@ast
Polymorphisms in UDP glucurono ...... uences and clinical relevance.
@en
Polymorphisms in UDP glucurono ...... uences and clinical relevance.
@nl
prefLabel
Polymorphisms in UDP glucurono ...... uences and clinical relevance.
@ast
Polymorphisms in UDP glucurono ...... uences and clinical relevance.
@en
Polymorphisms in UDP glucurono ...... uences and clinical relevance.
@nl
P2860
P356
P1476
Polymorphisms in UDP glucurono ...... quences and clinical relevance
@en
P2093
J O Miners
P I Mackenzie
P2860
P304
P356
10.1515/CCLM.2000.129
P577
2000-09-01T00:00:00Z